BioSpace News Archive

Jaguar Health, Inc. today announced that Stacey Tinianov, MPH, a Board Certified Patient Advocate, has joined the Company’s Scientific Advisory Board (SAB).

Palisade Bio, Inc. today provided a clinical program update for its ead product candidate, LB1148, a broad-spectrum serine protease inhibitor which acts to neutralize digestive enzymes, potentially reducing intestinal damage.

Aerami Therapeutics (“Aerami”) today announced results from studies of AER-901 (inhaled imatinib) that support progression into a Phase 2 clinical trial in both pulmonary hypertension associated with interstitial lung disease (PH-ILD) and pulmonary arterial hypertension (PAH).

Peptilogics, a clinical-stage biotechnology company, today announced top-line interim data of PLG0206 in PJI patients from their ongoing Phase 1b trial.

Veracyte, Inc. (Nasdaq: VCYT) today announced new data suggesting its novel genomic tests may positively impact diagnosis and care for patients being evaluated for interstitial lung disease (ILD) or lung cancer.

ClearPoint Neuro, Inc. (NASDAQ: CLPT) a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it has entered into a multi-year license agreement with UCB (EURONEXT BRUSSELS: UCB), a global biopharmaceutical leader, to partner on drug delivery platforms for UCB’s gene therapy portfolio.

AXIM Biotechnologies, Inc. announced that through its distribution partner Verseá Ophthalmics it has received commitments from over 40 clinics across the United States for implementation of both of its FDA-cleared Dry Eye Disease diagnostic assays.

Cartherics Pty Ltd, a biotechnology company developing immune cell therapies for the treatment of cancer, announced today that it is presenting at the upcoming 2023 BIO International Convention June 5-8, 2023, in Boston, Massachusetts.

Results from a joint study between CIBMTR® (Center for International Blood and Marrow Transplant Research®)—a research collaboration between the National Marrow Donor Program® (NMDP)/Be The Match® and the Medical College of Wisconsin (MCW)—and the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) defining COVID-19 vaccine response in allogeneic hematopoietic cell transplantation (HCT) were recently published in eClinicalMedicine.

Northway Biotech announced the completion of its expansion project for cGMP manufacturing facilities in Waltham, Massachusetts.